Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for follow-up of prostate biopsy pathology revealing Atypical Small Acinar Proliferation (ASAP). Patient reports [no/mild/moderate] lower urinary tract symptoms (LUTS). PSA levels are [value] ng/mL. No history of prior prostate cancer. Discussion regarding the significance of ASAP as a suspicious but non-diagnostic finding for adenocarcinoma.
Clinical Examination Findings
Digital Rectal Examination (DRE) reveals a prostate gland of approximately [size] grams. Consistency is [smooth/nodular/firm/asymmetric]. No palpable discrete indurated nodules suggestive of clinical T2 disease. No evidence of pelvic lymphadenopathy or suprapubic tenderness.
Treatment Protocol
Plan: 1. Close clinical surveillance with serial PSA monitoring every 3-6 months. 2. Repeat prostate biopsy recommended in [3-6] months to rule out underlying adenocarcinoma. 3. Consider multiparametric MRI (mpMRI) of the prostate to guide targeted re-biopsy. 4. Maintain current medical management for LUTS if applicable.